CroíValve
Series B in 2024
CroiValve Limited, founded in 2016 and based in Dublin, Ireland, specializes in the development of a medical device aimed at treating severe tricuspid regurgitation through a minimally invasive procedure. The company's innovative device allows for percutaneous delivery via a vein into the right heart, effectively sealing the gap between the native tricuspid valve leaflets. This approach restores proper valve function and prevents regurgitation, enabling healthcare professionals to address this condition in a safe, effective, and cost-efficient manner. CroiValve's solution is designed to be user-friendly, catering to a broad range of patients suffering from this serious heart issue.
PlasmaBound
Venture Round in 2022
PlasmaBound Ltd. is a Dublin-based company that specializes in advanced surface treatment technologies for fibre-reinforced composites. Established in 2017, PlasmaBound develops a proprietary method known as Controlled Plasma Ablation (CPA). This innovative technology modifies atmospheric plasma to enhance the bonding of lightweight materials, specifically carbon and glass fibre composites, allowing for strong and resilient adhesive joins. By facilitating reliable structural adhesive joining, PlasmaBound’s solutions significantly reduce the payload of heavy assemblies and improve reject rates in manufacturing processes. The company's services cater to various industries, including aerospace, transportation, marine, renewable energy, and consumer electronics, promoting the wider adoption of lightweight composite materials in multi-material structural assemblies.
CroíValve
Series A in 2022
CroiValve Limited, founded in 2016 and based in Dublin, Ireland, specializes in the development of a medical device aimed at treating severe tricuspid regurgitation through a minimally invasive procedure. The company's innovative device allows for percutaneous delivery via a vein into the right heart, effectively sealing the gap between the native tricuspid valve leaflets. This approach restores proper valve function and prevents regurgitation, enabling healthcare professionals to address this condition in a safe, effective, and cost-efficient manner. CroiValve's solution is designed to be user-friendly, catering to a broad range of patients suffering from this serious heart issue.
ProVerum Medical
Series A in 2022
ProVerum Medical is a medtech company that develops minimally invasive devices to treat benign prostatic hyperplasia. Its technology enables safe and effective BPH treatment in a doctor's office or operating room in a less invasive, more patient-friendly manner than traditional approaches. The flexible delivery system uses 3-D geometry to engage prostate anatomy, delivering radial force to the prostatic lobes without cutting, piercing, or heating tissue, with precise deployment under direct visualization. The design is reversible for removal at any time and atraumatic, reducing bleeding and catheterization, and it offers a universal fit to accommodate diverse anatomies, enabling clinicians to treat urinary obstruction caused by prostate enlargement effectively.
Tympany Medical
Seed Round in 2021
Tympany Medical develops a platform for minimally invasive ear surgeries. Its device enables surgeons to perform complex procedures using sterile endoscopy, reducing unnecessary mastoidectomies and enhancing surgical outcomes.
LUMA Vision
Series A in 2021
LUMA Vision develops connected intravascular medical devices to support the treatment of cardiac arrhythmias. Using advanced four-dimensional imaging and artificial intelligence with real-time tissue analysis, the company enhances electrophysiology and structural heart interventions, aiming to improve patient outcomes, increase procedural safety, and reduce healthcare system costs.
TerminusDB
Seed Round in 2021
TerminusDB is a Dublin-based company that specializes in providing an open-source, full-featured in-memory graph database management system. Its platform is designed to transform inconsistent data sets into structured and integrated data, utilizing a rich query language known as WOQL. TerminusDB offers comprehensive revision control features, including branching, merging, and time-travel capabilities, which enhance data management and decision-making processes. The platform is aimed at helping users infer data from business objects and relationships, define governing rules, and automate the migration of relevant data for analytics. By focusing on data structuring to meet business needs, TerminusDB enables organizations to improve productivity and optimize efficiency.
Parvalis Therapeutics
Venture Round in 2021
Founded in 2020, Parvalis Therapeutics is a biotechnology company based in Dublin, Ireland. It specializes in developing novel immunotherapeutics to treat autoimmune disorders, inflammatory diseases, and cancer.
PlasmaBound
Seed Round in 2020
PlasmaBound Ltd. is a Dublin-based company that specializes in advanced surface treatment technologies for fibre-reinforced composites. Established in 2017, PlasmaBound develops a proprietary method known as Controlled Plasma Ablation (CPA). This innovative technology modifies atmospheric plasma to enhance the bonding of lightweight materials, specifically carbon and glass fibre composites, allowing for strong and resilient adhesive joins. By facilitating reliable structural adhesive joining, PlasmaBound’s solutions significantly reduce the payload of heavy assemblies and improve reject rates in manufacturing processes. The company's services cater to various industries, including aerospace, transportation, marine, renewable energy, and consumer electronics, promoting the wider adoption of lightweight composite materials in multi-material structural assemblies.
LUMA Vision
Series A in 2020
LUMA Vision develops connected intravascular medical devices to support the treatment of cardiac arrhythmias. Using advanced four-dimensional imaging and artificial intelligence with real-time tissue analysis, the company enhances electrophysiology and structural heart interventions, aiming to improve patient outcomes, increase procedural safety, and reduce healthcare system costs.
Output Sports
Seed Round in 2020
Output Sports, based in Dublin, Ireland, develops and markets wearable sensors for athlete performance optimization. It provides an end-to-end solution that uses signal processing and machine learning to assess multiple components of athletic performance and monitor training programs with a single wearable sensor. The company offers an off-field performance measuring tool that evaluates an athlete's readiness to train, provides training biofeedback, and supports injury management, enabling sports practitioners to optimize performance with portability, practicality, and accuracy.
AYLIEN is an artificial intelligence company that specializes in natural language processing and text analysis, offering APIs and platforms to help users understand and extract insights from large volumes of human-generated content. Its offerings include information retrieval, machine learning, and image recognition APIs, as well as tools for news intelligence and content analysis that serve developers, data scientists, marketers and academics. The company provides an open platform for building micro applications that convert unstructured or semi-structured data into structured, machine-readable information, and it offers products such as Talk.ee and an educational App Engine to enable automated data collection, categorization and updates on topics of interest. AYLIEN aims to empower enterprises to analyze text and images at scale and to turn diverse data sources into actionable insights.
AtriAN Medical
Seed Round in 2019
AtriAN Medical is an Irish medical device company based in Galway, a prominent center for medical technology innovation. The company is focused on commercializing advanced technology developed at the Mayo Clinic in the United States. AtriAN specializes in a medical device designed to treat atrial fibrillation by employing micro Pulsed Electric Fields (mPEF). This innovative approach selectively ablates hyperactive tissue while preserving surrounding myocardium, minimizing damage to the heart muscle. Utilizing a catheter, AtriAN's device delivers short pulses of electrical energy directly to the problematic areas, offering a targeted treatment option that enhances patient safety and outcomes.
CroíValve
Seed Round in 2019
CroiValve Limited, founded in 2016 and based in Dublin, Ireland, specializes in the development of a medical device aimed at treating severe tricuspid regurgitation through a minimally invasive procedure. The company's innovative device allows for percutaneous delivery via a vein into the right heart, effectively sealing the gap between the native tricuspid valve leaflets. This approach restores proper valve function and prevents regurgitation, enabling healthcare professionals to address this condition in a safe, effective, and cost-efficient manner. CroiValve's solution is designed to be user-friendly, catering to a broad range of patients suffering from this serious heart issue.
Pharma Latch
Seed Round in 2019
Pharma Latch, a division of Latch Medical, specializes in innovative drug and vaccine delivery systems, focusing on intradermal administration. The company has developed a unique tissue anchor system that employs micro-needle technology, featuring angled microneedles designed to painlessly penetrate the outer layers of the skin. This method not only enhances the patient experience but also ensures consistent needle penetration for effective delivery. By leveraging its core platform technology, Pharma Latch provides healthcare professionals with improved alternatives to traditional wound stitching, unlocking the potential of various drugs and vaccines in a more efficient manner.
CroíValve
Seed Round in 2019
CroiValve Limited, founded in 2016 and based in Dublin, Ireland, specializes in the development of a medical device aimed at treating severe tricuspid regurgitation through a minimally invasive procedure. The company's innovative device allows for percutaneous delivery via a vein into the right heart, effectively sealing the gap between the native tricuspid valve leaflets. This approach restores proper valve function and prevents regurgitation, enabling healthcare professionals to address this condition in a safe, effective, and cost-efficient manner. CroiValve's solution is designed to be user-friendly, catering to a broad range of patients suffering from this serious heart issue.
Danalto Limited
Seed Round in 2018
Founded in 2017, Danalto Limited specializes in IoT solutions and services. The company offers a range of devices, including d-AlignSpy for monitoring open-path communications links and d-GullySpy for flood detection. Its core service, d-IoT, is a managed solution enabling enterprises to gain operational insights through sensor data. Danalto caters to industries such as agriculture tech, facilities management, and utilities.
Kastus is an award-winning surface innovation company based in Ireland, founded in 2014 by John Browne after over a decade of research and development. The company specializes in patented antiviral and antibacterial surface coatings designed to enhance hygiene on various surfaces, particularly glass and ceramics. Kastus' technology has been validated by ISO standards and proven to kill over 99% of harmful bacteria, viruses, fungi, and antibiotic-resistant superbugs, including human coronavirus. This makes it highly effective for products that require continuous touch hygiene. In response to the COVID-19 pandemic, Kastus launched antiviral and antimicrobial screen protectors to help businesses reopen safely. The company has also received EU funding for developing innovative solutions to combat Covid-19.
Coras enables brands like Ryanair, Lufthansa, Wizz Air, and Air Asia to generate ancillary revenue through its ticketing and loyalty platform. Operating in over 50 countries, 350 cities, and supporting 20 languages and currencies, Coras facilitates global event sales and activities for travel partners. Recently, they launched Fida, a web3-based loyalty platform allowing customers to spend their points across multiple brand partners.
TerminusDB
Seed Round in 2018
TerminusDB is a Dublin-based company that specializes in providing an open-source, full-featured in-memory graph database management system. Its platform is designed to transform inconsistent data sets into structured and integrated data, utilizing a rich query language known as WOQL. TerminusDB offers comprehensive revision control features, including branching, merging, and time-travel capabilities, which enhance data management and decision-making processes. The platform is aimed at helping users infer data from business objects and relationships, define governing rules, and automate the migration of relevant data for analytics. By focusing on data structuring to meet business needs, TerminusDB enables organizations to improve productivity and optimize efficiency.
Volograms
Seed Round in 2018
Volograms Limited is a Dublin-based company that specializes in volumetric video processing, transforming 2D videos into immersive volumetric holograms. Founded in 2018, Volograms has developed a mobile content creation platform called Volu, which utilizes artificial intelligence to enable users to generate 3D content for augmented reality applications. This innovative technology allows smartphone users to create, share, and interact with dynamic content from a simple video, catering to various use cases, including digital productions, fan engagement, and enterprise training. Volograms aims to democratize access to advanced content creation tools, making immersive communications accessible to a broader audience.
ProVerum Medical
Seed Round in 2018
ProVerum Medical is a medtech company that develops minimally invasive devices to treat benign prostatic hyperplasia. Its technology enables safe and effective BPH treatment in a doctor's office or operating room in a less invasive, more patient-friendly manner than traditional approaches. The flexible delivery system uses 3-D geometry to engage prostate anatomy, delivering radial force to the prostatic lobes without cutting, piercing, or heating tissue, with precise deployment under direct visualization. The design is reversible for removal at any time and atraumatic, reducing bleeding and catheterization, and it offers a universal fit to accommodate diverse anatomies, enabling clinicians to treat urinary obstruction caused by prostate enlargement effectively.
Siren offers an investigative intelligence platform that connects, federates, and extends data from open sources, vendors, and other data types to support risk analysis across national security, public safety, fraud and compliance, and cyber threat contexts. The platform uses artificial intelligence alongside search, business intelligence, big data, graphs, and knowledge representation to enable temporal analysis, full-text search with phonetics, misspellings, and highlighting, scientific visualizations, and time analysis, allowing analysts to analyze risks, threats, and crimes at scale. Siren's technology is search-based and patented, providing easy-to-use analytics, visualization, and reporting across all data types and data volumes. The company is recognized for its growth and innovation, including inclusion in the Deloitte Technology Fast 50 (2022) and a Gartner Cool Vendor designation (2020).
Irish Global Health Education Innovation
Series A in 2017
iheed is an online medical education company that designs, develops, and delivers online accredited post-graduate education programs and degrees in partnership with medical universities. The company is built by doctors and healthcare professionals (HCPs) for doctors and healthcare professionals.
iheed offers certificate, diploma, and Masters level education material to HCPs, packaged in modules. It utilizes technologies to offer the students a personalized, multi-sensory, multi-device learning experience suited to their learning style. Its programs and courses are adapted to the requirements of the healthcare system in different countries combining global best practice in medical training with local population healthcare needs. Its programs and courses are aimed at addressing the broad topics of healthcare need for frontline HCPs globally such as diabetes, women’s health, neurodegenerative diseases, cardiology, travel medicine, infection control, emergency medicine, disaster planning, research methodologies, practice management, nursing and pharmacology, and more.
The iheed Online Learning Environment (OLE) is a next generation cloud-based platform for online education supports interactive case-based learning methods, provides practical real-world education for practicing clinicians, and helps them build up their clinical, professional, and communication skills in patient consultation. It offers a number of features aimed at tutors and administrators such as rubrics, Speedgrader, and Turnitin to support tutors in reviewing and grading student assignments, extensive reporting and analytics, targeted messaging, and various views that enable tutors to identify students that are not keeping up with the instruction or meeting pre-defined learning thresholds.
Tutors of iheed’s Tutor Network hold weekly, bi-monthly, and per topic tutorial discussions via the web conferencing system within the iheed OLE platform to ensure students are aware of what is expected of them each week, and to discuss the key learning points in the context of the students’ day-to-day practices.
iheed works in partnership with many medical universities, global health organizations, and technology companies, including University of Florida Health, Qualcomm, Hamad International Training Center, Johnson & Johnson, Health Human Resources Development Center, HP, Harvard School of Public Health, Tropical Medical Bureau, and Alliance Boots.
Iheed was founded in 2010 and is based in Dublin, Ireland.
AYLIEN
Venture Round in 2017
AYLIEN is an artificial intelligence company that specializes in natural language processing and text analysis, offering APIs and platforms to help users understand and extract insights from large volumes of human-generated content. Its offerings include information retrieval, machine learning, and image recognition APIs, as well as tools for news intelligence and content analysis that serve developers, data scientists, marketers and academics. The company provides an open platform for building micro applications that convert unstructured or semi-structured data into structured, machine-readable information, and it offers products such as Talk.ee and an educational App Engine to enable automated data collection, categorization and updates on topics of interest. AYLIEN aims to empower enterprises to analyze text and images at scale and to turn diverse data sources into actionable insights.
Coras enables brands like Ryanair, Lufthansa, Wizz Air, and Air Asia to generate ancillary revenue through its ticketing and loyalty platform. Operating in over 50 countries, 350 cities, and supporting 20 languages and currencies, Coras facilitates global event sales and activities for travel partners. Recently, they launched Fida, a web3-based loyalty platform allowing customers to spend their points across multiple brand partners.
Ambisense
Seed Round in 2017
Founded in 2008, Ambisense designs and manufactures field-deployable, solar-powered autonomous monitoring systems for remote environmental parameter tracking. Their IoT-based solutions collect data periodically, analyze it in the cloud, and enable real-time alerts or downstream processes for gas emissions management across various industries like landfills, oil & gas sites, water treatment facilities, and biogas plants.
Siren offers an investigative intelligence platform that connects, federates, and extends data from open sources, vendors, and other data types to support risk analysis across national security, public safety, fraud and compliance, and cyber threat contexts. The platform uses artificial intelligence alongside search, business intelligence, big data, graphs, and knowledge representation to enable temporal analysis, full-text search with phonetics, misspellings, and highlighting, scientific visualizations, and time analysis, allowing analysts to analyze risks, threats, and crimes at scale. Siren's technology is search-based and patented, providing easy-to-use analytics, visualization, and reporting across all data types and data volumes. The company is recognized for its growth and innovation, including inclusion in the Deloitte Technology Fast 50 (2022) and a Gartner Cool Vendor designation (2020).
Petronics
Seed Round in 2017
Petronics is a company that develops robotic pets specifically designed for cats. Founded in 2014 and based in Champaign, Illinois, it offers a flagship product called Mousr, a robotic toy that features 360-degree vision, environmental sensing, and Bluetooth connectivity. These innovative products aim to engage indoor cats in play that mimics hunting behavior, promoting physical activity and helping to reduce obesity in pets. Through its advanced technology, Petronics seeks to enhance the interaction between cats and their owners while providing a stimulating environment for feline companions.
Kastus is an award-winning surface innovation company based in Ireland, founded in 2014 by John Browne after over a decade of research and development. The company specializes in patented antiviral and antibacterial surface coatings designed to enhance hygiene on various surfaces, particularly glass and ceramics. Kastus' technology has been validated by ISO standards and proven to kill over 99% of harmful bacteria, viruses, fungi, and antibiotic-resistant superbugs, including human coronavirus. This makes it highly effective for products that require continuous touch hygiene. In response to the COVID-19 pandemic, Kastus launched antiviral and antimicrobial screen protectors to help businesses reopen safely. The company has also received EU funding for developing innovative solutions to combat Covid-19.
ProVerum Medical
Seed Round in 2016
ProVerum Medical is a medtech company that develops minimally invasive devices to treat benign prostatic hyperplasia. Its technology enables safe and effective BPH treatment in a doctor's office or operating room in a less invasive, more patient-friendly manner than traditional approaches. The flexible delivery system uses 3-D geometry to engage prostate anatomy, delivering radial force to the prostatic lobes without cutting, piercing, or heating tissue, with precise deployment under direct visualization. The design is reversible for removal at any time and atraumatic, reducing bleeding and catheterization, and it offers a universal fit to accommodate diverse anatomies, enabling clinicians to treat urinary obstruction caused by prostate enlargement effectively.